Drug Shortage Report for PMS-AMLODIPINE-ATORVASTATIN

Last updated on 2020-04-02 History
Report ID 1726
Drug Identification Number 02404222
Brand name PMS-AMLODIPINE-ATORVASTATIN
Common or Proper name Amlodipine-Atorvastatin
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) AMLODIPINE ATORVASTATIN
Strength(s) 5MG 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2015-07-07
Estimated end date Unknown
Actual end date 2020-04-01
Shortage status Resolved
Updated date 2020-04-02
Company comments Product to be discontinued. It will be relaunched under new DIN
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-04-02 French Compare
v4 2020-04-02 English Compare
v3 2017-03-13 French Compare
v2 2017-03-13 English Compare
v1 2017-03-13 English Compare

Showing 1 to 5 of 5